Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 29 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10351606

    Mutated Salmonella enterica

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  2. US 10351844

    Methods and compositions for treating leber congenital amaurosis

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  3. US 10350306

    Methods and compositions for treating genetically linked diseases of the eye

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  4. US 10351587

    Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  5. US 10350273

    Treatment of hormonal disorders of growth

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  6. US 10350312

    Magnetic microstructures for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  7. US 10342871

    Compositions containing nucleosides and manganese and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  8. US 10342791

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    The United States of America as represented by the Secretary of the Army · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  9. US 10335478

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  10. US 10335465

    Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP

    The United States of America as represented by the Secretary of the Army · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  11. US 10335426

    N-acetyl mannosammine as a therapeutic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  12. US 10335460

    IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  13. US 10335423

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  14. US 10335365

    Bladder cancer specific ligand peptides

    The United States of America as represented by the Department of Veteran Affairs (Washington DC) · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  15. US 10329259

    Pyrazole derivatives and their use as cannabinoid receptor mediators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  16. US 10329339

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  17. US 10322125

    TGF-beta enhancing compositions for cartilage repair and methods related thereto

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  18. US 10323083

    Agents that specifically bind matrilin-3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  19. US 10322146

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  20. US 10314900

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  21. US 10314924

    RPGR gene therapy for retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  22. US 10316289

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  23. US 10314908

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as represented by the Secretary of the Department of · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  24. US 10307476

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.